Cross Country Healthcare Inc. Common Stock $0.0001 Par Value (CCRN)
FairStock Score: 39/100 — MIXED
Key Financials
| Current Price | $13.25 |
| Market Cap | $322M |
| P/E Ratio | -4.34 |
| ROE | -26.98% |
| Dividend Yield | —% |
| Sector | Healthcare |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
I approach this as Graham would: first ask what is behind the ticker, then ask what price protects me if I am wrong. Cross Country Healthcare is a healthcare staffing intermediary. Its latest reported quarter, fiscal Q1 2026, produced $241.1 million of revenue and a $4.3 million net loss, a -1.77% margin. The packet's growth numbers are poor, with revenue growth of -17.84% and profit growth of -770.61%, though the period is not named. At the 2026-07-28 close of $13.25, FairStock calculates a market cap of $322.0 million, a negative P/E of -4.34 on EPS of -$3.05, and a P/B of 1.32. FairStock calculations show return on equity of -26.98% and ROCE of -0.10%, so capital is not earning a return. The balance sheet is a bright spot: debt-to-equity is 0.01, and trailing free cash flow is $39.6 million, giving a 12.3% FCF yield. Piotroski is 6/9 and Altman Z is 2.84. The FairStock Score is 39/100, and its Lynch category is none because only 0 years of filed results are available and three are needed. A low beta of 0.45 and a 52-week range of $7.43 to $13.45 suggest little market excitement. This is not a moat business; staffing is competitive and tied to hospital demand. I would need evidence that losses are temporary and free cash flow is durable before calling the price a bargain.
In plain English: Cross Country Healthcare supplies temporary nurses, doctors and other medical staff to hospitals and healthcare clients. In its latest reported quarter, fiscal Q1 2026, revenue was $241.1 million and it lost $4.3 million, so the business looks weak right now. At $13.25 a share on 2026-07-28, the price is near the high end of its 52-week range and does not look clearly cheap given the losses, even though the company still produces cash.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data as of 2026-07-28 close · note generated 2026-10-15 · model deepseek-flash
Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer